Form 4: Zeev Weiner receives 25,000 stock options at $1.90 for QT Imaging
Rhea-AI Filing Summary
Zeev Weiner, a director of QT Imaging Holdings, Inc. (QTI/QTIH), was granted 25,000 stock options on 08/11/2025 with an exercise price of $1.90. The option award is reported as a direct holding and the filing shows 25,000 derivative securities beneficially owned following the transaction.
The grant vests one-third on August 15, 2026, with the remaining two-thirds vesting in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, resulting in full vesting on August 15, 2028, subject to continued service. The Form 4 is signed by Zeev Weiner on 08/13/2025 and lists an expiration date of 08/11/2035 for the option term as reported.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director equity award of 25,000 options at $1.90 with multi-year vesting; disclosure is standard and appears governance-compliant.
The filing documents a standard equity-based grant to a director, disclosed on Form 4. Key facts in the filing are the grant size of 25,000 options, an $1.90 exercise price, the reported transaction date 08/11/2025, and a signed filing date 08/13/2025. The vesting schedule—one-third on August 15, 2026, then quarterly installments through August 15, 2028—is explicitly stated. Based solely on the filing text, this is a routine compensation disclosure rather than a governance event raising immediate concerns.
TL;DR: The award is a 25,000-option stock option grant exercisable at $1.90, with staged vesting completing August 15, 2028 and an expiration reported as 08/11/2035.
The Form 4 reports acquisition of 25,000 stock options with an exercise price of $1.90 and a transaction date of 08/11/2025. The vesting timetable in the explanation section is explicit: one-third vests August 15, 2026, and the balance vests in eight equal quarterly installments culminating August 15, 2028, conditional on continued service. The filing lists the options as directly owned following the transaction. From the filing alone, the grant is a standard equity compensation instrument; materiality cannot be assessed without additional capital structure context.
FAQ
What did Zeev Weiner report on the Form 4 for QT Imaging (QTI)?
What is the vesting schedule for the options reported in the QTI Form 4?
How many derivative securities does the reporting person beneficially own after the transaction?
What exercise price and expiration are shown for the granted options?
What is Zeev Weiner's relationship to QT Imaging and when was the Form 4 signed?